Determination of sparfloxacin in plasma and urine by a simple and rapid liquid chromatographic method

Therapeutic Drug Monitoring

Volumn 21, Issue 4, 1999, Pages 411-415

  Kamberi, Marika ^a   Kamberi, Perparim ^a   Hajime, Nakashima ^a   Uemura, Naoto ^a   Nakamura, Koichi ^a   Nakano, Shigeyuki ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

High performance liquid chromatography; Plasma; Sparfloxacin; Ultraviolet detection; Urine

Indexed keywords

GREPAFLOXACIN; PERCHLORIC ACID; PLASMA PROTEIN; SPARFLOXACIN;

ARTICLE; CONTROLLED STUDY; DILUTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; DRUG URINE LEVEL; HUMAN; HUMAN TISSUE; PRECIPITATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY;

ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; FLUOROQUINOLONES; HUMANS; PIPERAZINES; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0032807815     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199908000-00005     Document Type: Article

References (8)

1. Goa KL, Bryson HM, Markham A. Sparfloxacin: A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections. Drugs 1997; 53:700-25.
2. Jones RN, Barrett BS, Erwin ME. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD-131150) compared with numerous other quinolone compounds. Diagn Microbiol Infect Dis 1991;14:319-30.
3. Dainippon Pharmaceutical Company. Determination of AT-4140 and its metabolites in plasma, urine and bile. Osaka, Japan: Dainippon Pharmaceutical Company; Document AT-4140-D103.
4. Bruno R, Verginol JC, Montey G, Galliot G. Dosage du RP62206 (AT-4140) par CLHP dans le plasma apres extraction solide (liquide automatisee) et dans lurine apres injection directe; Rhone Poulenc Sante ST/IBP/Biodyn 1419, Antony, France; 1990.
5. Borner K, Borner E, Lode H. Determination of sparfloxacin in serum and urine by high-performance liquid chromatography. J Chromatogr Biomed App 1992;579:285-89.
6. Lyon DJ, Cheung CY, Chan CY, Cheng BFA. Rapid HPLC assay of clinafloxacin, fleroxacin, levofloxacin, sparafloxacin and tosufloxacin. J Antimicrob Chemother 1994;34:446-8.
7. Montey G, Bruno R, Verginol CJ, et al. Pharmacokinetics of sparfloxacin in humans after single oral administration of doses 200, 400, 600 and 800 mg. J Clin Pharmacol 1994;34:1071-6.
8. Sorgel F, Ulrich J, Naber K, Ulrich S. Pharmacokinetic disposition of quinolones in human body fluids and tissues. Clin Pharmacokinet 1989;16(suppl 1):5-24.